Johnson & Johnson (JNJ)

204.39 -1.36 (-0.66%) USD  |  NYSE  |  Jan 09, 16:00
204.50 +0.11 (+0.05%) After-Hours: 20:00
More

Johnson & Johnson Research and Development Expense (Quarterly): 3.693B for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for JNJ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 1.90B
Gilead Sciences, Inc. 1.334B
Eli Lilly & Co. 3.466B
Regeneron Pharmaceuticals, Inc. 1.338B
Protagonist Therapeutics, Inc. 40.00M